{
  "market_name": "Hemostats Market",
  "unit": "Billion",
  "cagr": 6.9,
  "value_2024": 3.2,
  "value_2033": 5.83,
  "REGIONAL_RANKING": {
    "first": "North America",
    "second": "Europe",
    "third": "Asia Pacific"
  },
  "EUROPE_COUNTRY_CLASSIFICATION": {
    "Germany": "dominant",
    "United Kingdom": "fastest_growing",
    "France": "emerging"
  },
  "SEGMENTS": {
    "Type": [
      "Active Hemostats",
      "Passive Hemostats"
    ],
    "Formulation": [
      "Matrix & Gel Hemostats",
      "Sheet & Pad Hemostats",
      "Sponge Hemostats",
      "Powder Hemostats"
    ],
    "Application": [
      "Orthopedic Surgery",
      "General Surgery",
      "Neurological Surgery",
      "Cardiovascular Surgery",
      "Reconstructive Surgery",
      "Gynecological Surgery",
      "Trauma Management",
      "Plastic Surgery",
      "Dental Treatments",
      "Other Applications"
    ],
    "End User": [
      "Hospitals",
      "Ambulatory Surgical Centers",
      "Specialty Clinics",
      "Nursing Homes",
      "Others"
    ]
  }
}